Form D · Biotechnology
IKOTECH, LLC
New Albany, IN · CIK 0001462864
Offering snapshot reported Jun 7, 2011 · SEC filing
- Reported sold
- $175K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 27, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2011 | Initial | $175,000 | No comparison | 3 | SEC filing |
| May 4, 2009 | Initial | $100,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-160911
Convertible Promissory Note
Source: Form D, filed Jun 7, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Barnard | Executive |
| Rex Bickers, M.D. | Executive |
| Mark W. Crane | Executive |
| Mark S. Deuser | Executive |
| Nigel M. Ferrey | Executive |
| David Kennedy | Executive |
| James Leary, Ph.D. | Executive |
| Nicholas E. Mathioudakis | Executive |
| Paul Todd, Ph.D. | Executive |
| John C. Vellinger | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3000 Technology Avenue Suite N2207
New Albany, IN, 47150
New Albany, IN, 47150